Biliary elimination and pharmacokinetics of vinorelbine in micropigs. 1993

D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
Laboratory of Pharmacokinetics, Institute of Bacteriology, Strasbourg, France.

The biliary elimination and pharmacokinetics of vinorelbine (NVB) were investigated in five conscious micropigs provided with a double-terminal choledocal fistula allowing the collection and reinstillation of bile. After the i.v. administration of NVB (0.5 mg/kg), serum and bile samples were collected over a 48-h period. The concentrations of NVB were measured by high-performance liquid chromatography. The serum concentrations decreased rapidly from a maximal value of 208.6 ng/ml (SD, 111.7 ng/ml). The mean half-life was 10.9 h (SD, 8.6 h) and the mean AUC0-48 h was 292.8 ng ml-1 h (SD, 79.4 ng ml-1 h). The bile concentrations were high, amounting to 16.0 micrograms/ml (range, 5.4-27.7 micrograms/ml). The 0- to 48-h biliary excretion of unchanged NVB accounted for 25.8% (SD, 5.7%) of the injected dose, with 21.5% (SD, 4.0%) being eliminated during the 0- to 8-h period. Desacetyl-NVB was found in an inconstant manner and in very low amounts in bile samples. In addition, no glucuronide of NVB could be detected. Thus, in the micropig, biliary excretion represents an important route of elimination for NVB.

UI MeSH Term Description Entries
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000077235 Vinorelbine A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES. 5'-Nor-anhydrovinblastine,KW 2307,KW-2307,Navelbine,Vinorelbine Tartrate,5' Nor anhydrovinblastine,KW2307
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013556 Swine, Miniature Genetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature. Miniature Swine,Minipigs,Miniature Swines,Minipig,Swines, Miniature
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
August 1992, The Journal of antimicrobial chemotherapy,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
January 1992, European journal of clinical pharmacology,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
September 1996, Clinical pharmacokinetics,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
December 1977, The Journal of pharmacology and experimental therapeutics,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
October 1994, Seminars in oncology,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
August 2019, Cancer chemotherapy and pharmacology,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
January 1996, Clinical pharmacology and therapeutics,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
June 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
December 1992, Journal of clinical pharmacology,
D Levêque, and M Merle-Melet, and L Bresler, and J P Didelot, and J P Aymard, and J Wihlm, and F Jehl
September 1992, Toxicology and applied pharmacology,
Copied contents to your clipboard!